乳癌細胞α9尼古丁受體作為新穎靶向RNA奈米藥物與T細胞療法之臨床轉譯 研究-乳癌細胞α9尼古丁受體/HER2複合體作為RNA奈米藥物治療HerceptinR抗藥 性之機制探討(2/3)

  • Ho, Yuan-Soon (PI)

Project: A - Government Institutionb - Ministry of Science and Technology

Project Details

StatusFinished
Effective start/end date8/1/217/31/22